UnknownNot Applicable

Family History Study on Cancer Risk

United States18,623 participantsStarted 2020-07-01

Plain-language summary

This study aims to identify the optimal method to recognize, risk stratify, and provide follow-up care for individuals at risk of hereditary cancer. The study team will conduct a Hybrid Type II comparative effectiveness-implementation trial, with a mixed methods component and process/formative evaluations for stakeholder engagement. The study team will evaluate three methods for identifying and risk-stratifying individuals at risk of hereditary cancer and providing post-risk stratification longitudinal care.

Who can participate

Age range25 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult patients with ≥2 years of prior membership, ≥1 clinical visit in prior two years, and a listed email are eligible * Patients must also have received healthcare services during the past 2 years at Kaiser Permanente Northern California (KPNC) sampling sites Exclusion Criteria: * Patients outside the targeted geographic area * Patients who cannot speak or read English (given some survey instruments are validated only in English) * Kaiser Permanente Northern California members in the no-contact database for research studies

What they're measuring

Number of patients identified at high risk of cancer

Timeframe: 0 to 12 months

Trial details

NCT IDNCT04145388

SponsorKaiser Permanente

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-03-15

View on ClinicalTrials.gov More Lynch Syndrome trials